Eplontersen | Interleukin Related interleukin-related.com

Product Name :
Eplontersen

Search keywords :
Eplontersen

drugId :
null

Target Vo:
Transthyretin

Target Vo Short Name :
TTR

Moa_Name:
Transthyretin inhibitors

First Approval Country :
United States

First Approval Date Filter:
2023

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :
Astrazeneca Ab

Active Indication_Name:
Transthyretin amyloidosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ASC Rabbit pAb custom synthesis
Naxitamab Data Sheet
Hsp70 1B Antibody: Hsp70 1B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Hsp70 1B. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts